scispace - formally typeset
Journal ArticleDOI

New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity

Reads0
Chats0
TLDR
New insights into purine metabolism including the role of XOR activity are discussed in this review, indicating differential regulation of hypoxanthine and xanthine in a general population.
Abstract
Xanthine oxidoreductase (XOR) consists of two different forms, xanthine dehydrogenase and xanthine oxidase (XO), and is a rate-limiting enzyme of uric acid production from hypoxanthine and xanthine. Uric acid is the end product of purine metabolism in humans and has a powerful antioxidant effect. The lack of ascorbic acid, known as vitamin C, in hominoids has been thought to cause a compensatory increase in uric acid as an antioxidant by unfunctional gene mutation of uricase to a pseudogene. Because XO is involved in an increase in reactive oxygen species (ROS) by generating superoxide and hydrogen peroxide, inadequate activation of XOR promotes oxidative stress-related tissue injury. Plasma XOR activity is associated with obesity, smoking, liver dysfunction, hyperuricemia, dyslipidemia, insulin resistance, and adipokines, indicating a novel biomarker of metabolic disorders. However, XOR activity in adipose tissue is low in humans unlike in rodents, and hypoxanthine is secreted from human adipose tissue. The concentration of hypoxanthine, but not xanthine, is independently associated with obesity in a general population, indicating differential regulation of hypoxanthine and xanthine. Treatment with an XOR inhibitor can decrease uric acid for preventing gout, reduce production of XO-related ROS, and promote reutilization of hypoxanthine and ATP production through the salvage pathway. It has recently been suggested that discontinuation of an XOR inhibitor causes adverse cardiovascular outcomes as XOR inhibitor withdrawal syndrome, possibly due to cardiac disturbance of conduction and contraction by reduced ATP production. New insights into purine metabolism, including the role of XOR activity in the past 5 yr, are mainly discussed in this review.

read more

Citations
More filters
Journal ArticleDOI

Uric acid and cardiovascular disease: A clinical review.

TL;DR: In this article, a review article summarizes current evidence concerning the relation between hyperuricemia and cardiovascular diseases such as hypertension, atrial fibrillation, chronic kidney disease, heart failure, coronary artery disease, and cardiovascular death.
Journal ArticleDOI

Xanthine oxidoreductase: One enzyme for multiple physiological tasks.

TL;DR: XOR is a multiple-level regulated enzyme, resulting from a complicated evolutionary process that assigned it many physiological roles, such as xanthine dehydrogenase (XDH) and xanthines oxidoreductase(XO) as mentioned in this paper.
Journal ArticleDOI

From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies

TL;DR: In this article, a review enumerates various important considerations for designing and interpreting cellular and mitochondrial bioenergetics experiments, some common challenges and pitfalls in data interpretation, and some potential "next steps" to be taken that can address these highlighted challenges.
Journal ArticleDOI

Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction

TL;DR: Different cellular sources of ROS in diabetes and a new emerging paradigm of endothelial cell dysfunction as a key event in the pathogenesis of DKD are discussed.
Journal ArticleDOI

Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke

TL;DR: In this paper, mesenchymal stem cells (MSCs) and secretome were used for the treatment of ischemic stroke due to their pleiotropic effect.
References
More filters
Journal ArticleDOI

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

TL;DR: The central role of lipid chaperones — the fatty acid-binding proteins (FABPs) — in lipid-mediated biological processes and systemic metabolic homeostasis through the regulation of diverse lipid signals is discussed, and their therapeutic significance is highlighted.
Journal ArticleDOI

Sugar, Uric Acid, and the Etiology of Diabetes and Obesity

TL;DR: The hypothesis that fructose-mediated generation of uric acid may have a causal role in diabetes and obesity is revisited and new insights into pathogenesis and therapies for this important disease are provided.
Journal ArticleDOI

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

TL;DR: The mechanism of improvement in endothelial function with allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction, and it is shown that the steep dose–response relationship exists.
Journal ArticleDOI

Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study

TL;DR: In untreated subjects with essential hypertension, raised uric acid is a powerful risk marker for subsequent cardiovascular disease and all-cause mortality.
Related Papers (5)